• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
A Qualitative and Quantitative Comparison of Adverse Drug Reaction Data in Different Drug Information Sources.不同药物信息来源中药物不良反应数据的定性与定量比较
Int J Appl Basic Med Res. 2017 Oct-Dec;7(4):223-227. doi: 10.4103/ijabmr.IJABMR_18_17.
2
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.评估患者向英国“黄卡计划”报告药物不良反应的情况：文献回顾、描述性和定性分析以及问卷调查。
Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200.
3
Monitoring drug safety in Astrakhan, Russia.俄罗斯阿斯特拉罕地区的药物安全监测。
Int J Risk Saf Med. 2015;27 Suppl 1:S33-4. doi: 10.3233/JRS-150680.
4
'Have we missed reporting adverse drug reactions under Revised National TB Control Programme?' - A mixed method study in Bengaluru, India.“在修订后的国家结核病控制规划下，我们是否漏报了药物不良反应？”——印度班加罗尔的一项混合方法研究。
Indian J Tuberc. 2020 Jan;67(1):20-28. doi: 10.1016/j.ijtb.2020.01.003. Epub 2020 Jan 15.
5
Adverse drug reactions at adverse drug reaction monitoring center in Raipur: Analysis of spontaneous reports during 1 year.赖布尔市药品不良反应监测中心的药品不良反应：1年期间自发报告分析
Indian J Pharmacol. 2017 Nov-Dec;49(6):432-437. doi: 10.4103/ijp.IJP_781_16.
6
Difference in described indications of medicines among drug information sources in India: An issue urgently to be addressed.印度药品信息来源中所描述的药品适应症差异：一个亟待解决的问题。
J Nat Sci Biol Med. 2016 Jan-Jun;7(1):93-7. doi: 10.4103/0976-9668.175098.
7
A cross-sectional study of surveillance of adverse drug reactions in inpatient departments of a tertiary care hospital.一家三级护理医院住院部药品不良反应监测的横断面研究。
J Basic Clin Physiol Pharmacol. 2014 Feb;25(1):125-30. doi: 10.1515/jbcpp-2012-0077.
8
Comparison of Three Different Data Sources of Adverse Drug Reactions Using Adverse Drug Reaction Data of Fluorouracil for Gastric Cancer as an Example.比较三种不同不良反应数据来源，以氟尿嘧啶治疗胃癌不良反应数据为例。
Biol Pharm Bull. 2020;43(10):1476-1480. doi: 10.1248/bpb.b19-01080.
9
Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands.荷兰某大学医院儿科患者不良反应报告分析。
Paediatr Drugs. 2020 Aug;22(4):425-432. doi: 10.1007/s40272-020-00405-3.
10
Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.药品不良反应报告不足：印度药物警戒面临的一项挑战。
Indian J Pharmacol. 2015 Jan-Feb;47(1):65-71. doi: 10.4103/0253-7613.150344.

本文引用的文献

1
Influence of physician's education, drug information and medical-care settings on the quality of drugs prescribed.医生教育、药物信息及医疗环境对所开处方药物质量的影响。
Eur J Clin Pharmacol. 2000 Dec;56(9-10):747-53. doi: 10.1007/s002280000217.
2
Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems.介绍MEDWatch。一种报告药物和器械不良反应及产品问题的新方法。
JAMA. 1993 Jun 2;269(21):2765-8. doi: 10.1001/jama.269.21.2765.

不同药物信息来源中药物不良反应数据的定性与定量比较

A Qualitative and Quantitative Comparison of Adverse Drug Reaction Data in Different Drug Information Sources.

作者信息

Randhawa Gurpreet Kaur, Sharma Rajeev, Singh Navyug Raj, Sharma Nidhi

机构信息

Department of Pharmacology, Government Medical College, Amritsar, Punjab, India.

Department of Medicine, Guru Nanak Dev Hospital, Government Medical College, Amritsar, Punjab, India.

出版信息

Int J Appl Basic Med Res. 2017 Oct-Dec;7(4):223-227. doi: 10.4103/ijabmr.IJABMR_18_17.

DOI:10.4103/ijabmr.IJABMR_18_17
PMID:29308358
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5752805/
Abstract

BACKGROUND

For safe use of medicines, awareness regarding the existing knowledge of adverse drug reactions (ADRs) is essential to prevent, identify, and manage them.

AIM

The present study is planned to assess variation in documented ADRs of antihypertensive drugs in various sources of drug information.

MATERIAL AND METHODS

A cross-sectional, observational study was undertaken to analyze the different sources of ADRs-related information. Textbooks, National Formulary India (NFI), Drug Today (DT), and Current Index of Medical Specialties (CIMS) were analyzed for ADRs pertaining to nine antihypertensive groups comprising a total of 44 drugs. ADRs were categorized according to body systems, tabulated, and compared. Quantitative and qualitative analyses of ADRs and serious ADRs were done.

RESULTS AND DISCUSSION

Textbooks mostly provided ADRs of drug groups as a whole and not of individual drugs. None of the analyzed sources mentioned all antihypertensive drugs. DT contained information for the maximum number of drugs studied (81.8%) and NFI gave information for 29.7% drugs only. There was a wide variability among various resources while listing ADRs. NFI listed the maximum number of total ADRs, and least ADR information was provided by DT. NFI mentioned the maximum number of serious ADRs (47) for prototype drugs followed by CIMS (36) and DT (8). The quality of data was better in NFI, but none of the resources studied were found to be complete.

CONCLUSION

No source of information was complete in providing wholesome information of ADRs studied, and there was a wide variability in describing them.

摘要

背景

为安全用药，了解现有药物不良反应（ADR）知识对于预防、识别和处理这些反应至关重要。

目的

本研究旨在评估不同药物信息来源中抗高血压药物记录的ADR差异。

材料与方法

开展一项横断面观察性研究，以分析与ADR相关信息的不同来源。对教科书、《印度国家处方集》（NFI）、《今日药物》（DT）和《医学专业当前索引》（CIMS）中涉及9个抗高血压药物组（共44种药物）的ADR进行分析。ADR按身体系统分类、列表并比较。对ADR和严重ADR进行了定量和定性分析。

结果与讨论

教科书大多提供药物组整体的ADR，而非个别药物的ADR。所有分析来源均未提及所有抗高血压药物。DT包含所研究药物的最大数量信息（81.8%），而NFI仅提供29.7%药物的信息。在列出ADR时，各资源之间存在很大差异。NFI列出的ADR总数最多，DT提供的ADR信息最少。NFI提到原型药物的严重ADR数量最多（47种），其次是CIMS（36种）和DT（8种）。NFI的数据质量较好，但所研究的资源均不完整。

结论

在所研究的ADR信息来源中，没有一个能完整提供全面信息，且在描述这些信息时存在很大差异。